The Effects of Body Fat Reduction through the Metabolic Control of Steam-Processed Ginger Extract in High-Fat-Diet-Fed Mice

Author:

Lee Yeong-Geun12ORCID,Lee Sung Ryul3,Baek Hyun Jin1,Kwon Jeong Eun12ORCID,Baek Nam-In1ORCID,Kang Tong Ho1ORCID,Kim Hyunggun4ORCID,Kang Se Chan12ORCID

Affiliation:

1. Department of Oriental Medicine and Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea

2. BioMedical Research Institute, Kyung Hee University, Yongin 17104, Republic of Korea

3. Department of Convergence Biomedical Science, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan 47392, Republic of Korea

4. Department of Biomechatronic Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea

Abstract

The prevalence of metabolic syndrome is increasing globally due to behavioral and environmental changes. There are many therapeutic agents available for the treatment of chronic metabolic diseases, such as obesity and diabetes, but the data on their efficacy and safety are lacking. Through a pilot study by our group, Zingiber officinale rhizomes used as a spice and functional food were selected as an anti-obesity candidate. In this study, steam-processed ginger extract (GGE) was used and we compared its efficacy at alleviating metabolic syndrome-related symptoms with that of conventional ginger extract (GE). Compared with GE, GGE (25–100 μg/mL) had an increased antioxidant capacity and α-glucosidase inhibitory activity in vitro. GGE was better at suppressing the differentiation of 3T3-L1 adipocytes and lipid accumulation in HepG2 cells and promoting glucose utilization in C2C12 cells than GE. In 16-week high-fat-diet (HFD)-fed mice, GGE (100 and 200 mg/kg) improved biochemical profiles, including lipid status and liver function, to a greater extent than GE (200 mg/kg). The supplementation of HFD-fed mice with GGE (200 mg/kg) resulted in the downregulation of SREBP-1c and FAS gene expression in the liver. Collectively, our results indicate that GGE is a promising therapeutic for the treatment of obesity and metabolic syndrome.

Funder

Ministry of Agriculture, Food and Rural Affairs

Publisher

MDPI AG

Reference50 articles.

1. Natural anti-obesity agents;Mohamed;Bull. Fac. Pharm. Cairo Univ.,2014

2. Transcriptional control of adipocyte formation;Farmer;Cell Metab.,2006

3. Pharmacological Treatment for Non-alcoholic Fatty Liver Disease;Francque;Adv. Ther.,2019

4. Dietary fat, insulin sensitivity and the metabolic syndrome;Riccardi;Clin. Nutr.,2004

5. Food-derived regulatory factors against obesity and metabolic syndrome;Kawada;Biosci. Biotechnol. Biochem.,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3